Gland Pharma has named Ajay Sahni as the new CEO of its Singapore subsidiary, Gland Singapore, effective November 2, 2026.

Sanofi is set to pursue larger acquisitions and enhance its growth strategy under the leadership of CEO Belen Garijo, aiming ...

Senores Pharmaceuticals has announced its Q2 FY27 financial results, showcasing a 25% increase in revenue to ₹192 crore, ...

Granules India receives a form 483 from the FDA with 11 observations during inspection, highlighting process and ...

India's pharmaceutical industry has experienced unprecedented double-digit growth over the past four quarters, driven mainly ...

Laurus Labs expands its capabilities in the oligonucleotide and peptide sectors with strategic acquisitions, enhancing R&D, ...

Fresenius has entered a major development agreement with WuXi Biologics to enhance its biosimilars pipeline, targeting a market worth over €370 billion. This partnership aims to boost Fresenius’ ...

AstraZeneca reveals a strategic plan to save $1.5 billion annually for investment in its drug pipeline, signaling a ...

Sun Pharmaceutical Industries has received regulatory approval to manufacture and market its generic semaglutide pill in ...

A Delhi court discharges former Joint Drugs Controller Dr. S. Eswara Reddy and three others in a bribery case involving ...

Bengaluru: Karnataka Health Minister Dinesh Gundu Rao on Thursday launched a monitoring portal for the detection of NSQ drugs and the prevention of misuse of NDPS, aimed at strengthening surveillance, ...

Sun Pharma has voluntarily halted production of 11 ophthalmology drugs at its Assam facility following quality lapses flagged ...